Literature DB >> 12854112

Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach.

H Katai1, T Sano, T Fukagawa, H Shinohara, M Sasako.   

Abstract

BACKGROUND: Total gastrectomy with D2 dissection is the standard treatment in Japan for early upper-third gastric cancer. The purpose of this study was to confirm the safety and radicality of proximal gastrectomy as an alternative operation.
METHODS: Between 1993 and 1999, 45 patients with an apparent primary early gastric cancer in the upper third of the stomach were treated by proximal gastrectomy with jejunal interposition. The spleen was preserved, but the suprapancreatic nodes were cleared.
RESULTS: Histology confirmed early gastric cancer in 37 patients while eight had advanced disease. Nodal metastasis was observed in six patients. There was no hospital death and no early postoperative complications. One patient died from nodal recurrence and two from unrelated causes. Two patients had reflux symptoms without endoscopic oesophagitis. Mean weight loss was 11.5 per cent of initial bodyweight.
CONCLUSION: Proximal gastrectomy for early upper-third gastric cancer can be performed safely with an excellent cure rate. This procedure deserves further clinical evaluation to assess patients' quality of life. Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12854112     DOI: 10.1002/bjs.4106

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  60 in total

1.  A decade in gastric cancer curative surgery: Evidence of progress (1999-2009).

Authors:  Stefano Rausei; Gianlorenzo Dionigi; Francesca Rovera; Luigi Boni; Caterina Valerii; Luisa Giavarini; Francesco Frattini; Renzo Dionigi
Journal:  World J Gastrointest Surg       Date:  2012-03-27

2.  Stenosis of esophago-jejuno anastomosis after gastric surgery.

Authors:  Takeo Fukagawa; Takuji Gotoda; Ichiro Oda; Yasunori Deguchi; Makoto Saka; Shinji Morita; Hitoshi Katai
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

3.  Long-term results of proximal and total gastrectomy for adenocarcinoma of the upper third of the stomach.

Authors:  Chang Hak Yoo; Byung Ho Sohn; Won Kon Han; Won Kil Pae
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

4.  Issues in the management of the upper third gastric cancer.

Authors:  Han-Kwang Yang
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

5.  Gastric tube reconstruction reduces postoperative gastroesophageal reflux in adenocarcinoma of esophagogastric junction.

Authors:  Xiu-Feng Chen; Bo Zhang; Zhi-Xin Chen; Jian-Kun Hu; Bin Dai; Fang Wang; Hong-Xin Yang; Jia-Ping Chen
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

Review 6.  Quality of life: A critical outcome for all surgical treatments of gastric cancer.

Authors:  Michael D McCall; Peter J Graham; Oliver F Bathe
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

7.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

8.  Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study.

Authors:  Chang Hak Yoo; Byung Ho Sohn; Won Kon Han; Won Kil Pae
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

9.  Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience.

Authors:  Alberto Di Leo; Daniele Marrelli; Franco Roviello; Marco Bernini; AnnaMaria Minicozzi; Simone Giacopuzzi; Corrado Pedrazzani; Luca Gian Baiocchi; Giovanni de Manzoni
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

10.  Long-term outcome after proximal gastrectomy with jejunal interposition for gastric cancer compared with total gastrectomy.

Authors:  Isao Nozaki; Shinji Hato; Takaya Kobatake; Koji Ohta; Yoshirou Kubo; Akira Kurita
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.